CF Trust partners with NovaBiotics Ltd and Health Sciences Scotland for development of Lynovex

Lynovex®, a recognised treatment for a non CF-related condition, is being developed as a treatment for persistent lung infection in cystic fibrosis, thanks to a partnership between the Cystic Fibrosis Trust, Health Sciences Scotland and biotech company NovaBiotics Ltd. The … Continued